Literature DB >> 9499074

The nucleotide sequence and spliced pol mRNA levels of the nonprimate spumavirus bovine foamy virus.

D L Holzschu1, M A Delaney, R W Renshaw, J W Casey.   

Abstract

We have determined the complete nucleotide sequence of a replication-competent clone of bovine foamy virus (BFV) and have quantitated the amount of splice pol mRNA processed early in infection. The 544-amino-acid Gag protein precursor has little sequence similarity with its primate foamy virus homologs, but the putative nucleocapsid (NC) protein, like the primate NCs, contains the three glycine-arginine-rich regions that are postulated to bind genomic RNA during virion assembly. The BFV gag and pol open reading frames overlap, with pro and pol in the same translational frame. As with the human foamy virus (HFV) and feline foamy virus, we have detected a spliced pol mRNA by PCR. Quantitatively, this mRNA approximates the level of full-length genomic RNA early in infection. The integrase (IN) domain of reverse transcriptase does not contain the canonical HH-CC zinc finger motif present in all characterized retroviral INs, but it does contain a nearby histidine residue that could conceivably participate as a member of the zinc finger. The env gene encodes a protein that is over 40% identical in sequence to the HFV Env. By comparison, the Gag precursor of BFV is predicted to be only 28% identical to the HFV protein.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9499074      PMCID: PMC109513          DOI: 10.1128/JVI.72.3.2177-2182.1998

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Retroviral integrase domains: DNA binding and the recognition of LTR sequences.

Authors:  E Khan; J P Mack; R A Katz; J Kulkosky; A M Skalka
Journal:  Nucleic Acids Res       Date:  1991-02-25       Impact factor: 16.971

2.  Structural and evolutionary relationships between retroviral and eucaryotic aspartic proteinases.

Authors:  J K Rao; J W Erickson; A Wlodawer
Journal:  Biochemistry       Date:  1991-05-14       Impact factor: 3.162

3.  Transcriptional mapping of the 3' end of the bovine syncytial virus genome.

Authors:  R W Renshaw; J W Casey
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

4.  Human foamy virus genome possesses an internal, Bel-1-dependent and functional promoter.

Authors:  M Löchelt; W Muranyi; R M Flügel
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

Review 5.  Foamy viruses.

Authors:  D Neumann-Haefelin; U Fleps; R Renne; M Schweizer
Journal:  Intervirology       Date:  1993       Impact factor: 1.763

6.  Progressive encephalopathy and myopathy in transgenic mice expressing human foamy virus genes.

Authors:  K Bothe; A Aguzzi; H Lassmann; A Rethwilm; I Horak
Journal:  Science       Date:  1991-08-02       Impact factor: 47.728

7.  Structure and transcriptional status of bovine syncytial virus in cytopathic infections.

Authors:  R W Renshaw; M A Gonda; J W Casey
Journal:  Gene       Date:  1991-09-15       Impact factor: 3.688

8.  The human foamy virus internal promoter directs the expression of the functional Bel 1 transactivator and Bet protein early after infection.

Authors:  M Löchelt; R M Flügel; M Aboud
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

9.  Genomic organization and expression of simian foamy virus type 3 (SFV-3).

Authors:  R Renne; E Friedl; M Schweizer; U Fleps; R Turek; D Neumann-Haefelin
Journal:  Virology       Date:  1992-02       Impact factor: 3.616

10.  Bacterial expression of the capsid antigen domain and identification of native gag proteins in spumavirus-infected cells.

Authors:  A Bartholomä; W Muranyi; R M Flügel
Journal:  Virus Res       Date:  1992-04       Impact factor: 3.303

View more
  15 in total

1.  Identification of a conserved residue of foamy virus Gag required for intracellular capsid assembly.

Authors:  S W Eastman; M L Linial
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

Review 2.  Foamy viruses are unconventional retroviruses.

Authors:  M L Linial
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

3.  Identification and functional characterization of Bet protein as a negative regulator of BFV3026 replication.

Authors:  Tiejun Bing; Kai Wu; Xiaoxu Cui; Peng Shao; Qicheng Zhang; Xiaobo Bai; Juan Tan; Wentao Qiao
Journal:  Virus Genes       Date:  2014-03-11       Impact factor: 2.332

4.  Sequence and transcriptional analyses of the fish retroviruses walleye epidermal hyperplasia virus types 1 and 2: evidence for a gene duplication.

Authors:  L A LaPierre; D L Holzschu; P R Bowser; J W Casey
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

5.  Evidence that the human foamy virus genome is DNA.

Authors:  S F Yu; M D Sullivan; M L Linial
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

6.  Complete genome sequences of two novel European clade bovine foamy viruses from Germany and Poland.

Authors:  Torsten Hechler; Magdalena Materniak; Timo Kehl; Jacek Kuzmak; Martin Löchelt
Journal:  J Virol       Date:  2012-10       Impact factor: 5.103

7.  Characterization of a full-length infectious clone of bovine foamy virus 3026.

Authors:  Tiejun Bing; Hong Yu; Yue Li; Lei Sun; Juan Tan; Yunqi Geng; Wentao Qiao
Journal:  Virol Sin       Date:  2014-03-03       Impact factor: 4.327

8.  Determination of the relative amounts of Gag and Pol proteins in foamy virus particles.

Authors:  Marc Cartellieri; Wolfram Rudolph; Ottmar Herchenröder; Dirk Lindemann; Axel Rethwilm
Journal:  Retrovirology       Date:  2005-07-08       Impact factor: 4.602

Review 9.  Foamy virus assembly with emphasis on pol encapsidation.

Authors:  Eun-Gyung Lee; Carolyn R Stenbak; Maxine L Linial
Journal:  Viruses       Date:  2013-03-20       Impact factor: 5.048

Review 10.  Non-simian foamy viruses: molecular virology, tropism and prevalence and zoonotic/interspecies transmission.

Authors:  Timo Kehl; Juan Tan; Magdalena Materniak
Journal:  Viruses       Date:  2013-09-13       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.